ASC 323 Equity Method Investments — Core Rule
An investor applies the equity method to account for an investment in an investee when the investor has the ability to exercise significant influence over the investee's operating and financial policies, even if the investor does not control the investee (ASC 323-10-15-6).
How ASC 323 Equity Method Investments Works
- Significant influence threshold — Significant influence is presumed to exist when an investor owns 20% or more of the voting equity of an investee; however, the presumption is rebuttable, and the absence of ownership above 20% does not preclude significant influence (ASC 323-10-15-7 and ASC 323-10-15-8). Conversely, a lower ownership percentage combined with representation on the board of directors, participation in policy-making, or material intercompany transactions may establish significant influence.
- Exclusions from the equity method — An investor does not apply the equity method if it has control over the investee (requiring consolidation per ASC 810) or if the investee is a business development company, investment company, or certain other specialized entities that measure investments at fair value through net income per ASC 323-10-15-4 and ASC 946 (ASC 323-10-15-4A). Additionally, investments in variable interest entities where the investor is the primary beneficiary are consolidated, not equity-accounted (ASC 810-10-15-14).
- Elimination of unrealized profits and losses — Under the equity method, the investor recognizes its proportionate share of the investee's net income or loss; however, profits and losses on transactions between the investor and investee are eliminated to the extent of the investor's ownership interest until the assets are sold to third parties or consumed (ASC 323-10-40-1). This intercompany profit elimination is mandatory and operates like downstream and upstream elimination in consolidated statements.
- Initial recognition and subsequent remeasurement — The investment is initially recorded at cost (or fair value in a business combination) and adjusted upward or downward by the investor's share of the investee's earnings or losses and reduced by dividends received (ASC 323-10-30-1 and ASC 323-10-30-2). The carrying amount reflects the investor's equity in the investee's net assets plus or minus any goodwill component implicit in the acquisition.
- Impairment testing — The investment is tested for impairment using a qualitative or quantitative approach; if facts and circumstances indicate the carrying amount may not be recoverable, an impairment loss is recognized in earnings (ASC 323-10-35-33 through ASC 323-10-35-35). Unlike goodwill, equity method investments are not subject to mandatory annual impairment testing but are evaluated based on whether the investment value has been reduced below carrying amount on an other-than-temporary basis.
- Disclosure and presentation — The investor's share of earnings or losses from equity method investments is typically presented as a single line item on the income statement, and the investment is presented as a non-current asset on the balance sheet unless it is clearly expected to be sold within one year (ASC 323-10-50-1 and ASC 323-10-50-2). Significant judgments regarding the application of the equity method and the investee's financial condition must be disclosed.
ASC 323 Equity Method Investments — Practical Example
On January 2, 20X4, Investor Co. purchases 25% of the common stock of Investee Inc. for $5,000,000 cash. The 25% ownership stake is sufficient to establish a presumption of significant influence. For the year ended December 31, 20X4, Investee Inc. reports net income of $2,000,000. On December 15, 20X4, Investee Inc. declares and pays a dividend of $400,000 to Investor Co.
Initial investment (January 2, 20X4):
| Account | Debit | Credit |
|---|
| Dr. Investment in Investee Inc. | $5,000,000 | |
| Cr. Cash | | $5,000,000 |
Recognition of equity in Investee net income (December 31, 20X4):
Investor Co.'s share = 25% × $2,000,000 = $500,000
| Account | Debit | Credit |
|---|
| Dr. Investment in Investee Inc. | $500,000 | |
| Cr. Equity in Earnings of Investee | | $500,000 |
Receipt of dividend (December 15, 20X4):
| Account | Debit | Credit |
|---|
| Dr. Cash | $100,000 | |
| Cr. Investment in Investee Inc. | | $100,000 |
Balance sheet at December 31, 20X4
Investment in Investee Inc. = $5,000,000 + $500,000 – $100,000 = $5,400,000
ASC 323 Equity Method Investments — Common Pitfalls
- Conflating the 20% threshold with automatic control — A 20% ownership interest creates a rebuttable presumption of significant influence, not control. Many practitioners incorrectly assume that 20%–50% ownership automatically triggers equity method treatment without considering whether other facts negate influence (e.g., a passive investor with no board representation and blocked voting rights may not have significant influence despite 25% ownership).
- Failing to eliminate intercompany profits — Practitioners often forget to eliminate unrealized profits on upstream sales (investee to investor) and downstream sales (investor to investee). This is a frequent audit finding because the elimination is not intuitive when using a single-line equity method approach; the adjusting entry must reduce the equity earnings and the investment balance (ASC 323-10-40-1).
- Overlooking investee accounting changes and measurement period adjustments — When an investee changes accounting policies or makes measurement period adjustments within 12 months of acquisition, the investor must restate the investment carrying amount retroactively. Practitioners sometimes ignore these adjustments, resulting in an overstated or understated investment balance.
ASC 323 Equity Method Investments — Key Paragraphs
- ASC 323-10-15-6 (definition and conditions for significant influence)
- ASC 323-10-15-7, 323-10-15-8 (the 20% presumption and rebuttable nature)
- ASC 323-10-30-1, 323-10-30-2 (initial and subsequent measurement)
- ASC 323-10-40-1 (elimination of intercompany profits)
- ASC 323-10-35-33 through 323-10-35-35 (impairment testing)
- ASC 323-10-50-1, 323-10-50-2 (presentation and disclosure)